Clinical Trial Update: Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC

View source ↗

Summary

This completed clinical trial update analyzes treatment patterns and clinical outcomes of palbociclib combinations in hormone receptor-positive, HER2-negative m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer

Drugs mentioned

• IBRANCE (PALBOCICLIB)

Snippet

Sponsor: Pfizer | Conditions: Metastatic Breast Cancer | Status: COMPLETED